Atlas Trials

Phase 2

89,854 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 2

RecordFirmDate
Effect of Perioperative iv Dexmedetomidine vs. Lidocaine on Postoperative Pain, Analgesic Consumption and Recovery After Abdominal Gynaecological Surgery (NCT03363425)University of Athens2017-11-14
Study of Pembrolizumab (MK-3475) in Combination With Romidepsin (NCT03278782)M.D. Anderson Cancer Center2017-11-14
Validation of Sleep Apnea Screening Device Phase II (NCT03025464)University of Michigan2017-11-14
A Study Comparing Obinutuzumab and BGB-3111 Versus Obinutuzumab Alone in Treating R/R Follicular Lymphoma (NCT03332017)BeiGene2017-11-14
Study of Efficacy, Safety, and Quality of Life of Pazopanib in Patients With Advanced and/or Metastatic Renal Cell Carcinoma After Prior Checkpoint Inhibitor Treatment (NCT03200717)Novartis Pharmaceuticals2017-11-14
Combination Study of AZD5069 and Enzalutamide. (NCT03177187)Institute of Cancer Research, United Kingdom2017-11-13
A Study to Evaluate the Safety and Efficacy of Intravenous JNJ-64179375 Versus Oral Apixaban in Participants Undergoing Elective Total Knee Replacement Surgery (NCT03251482)Janssen Research & Development, LLC2017-11-13
Oral Fexinidazole Dosing Regimens for the Treatment of Adults With Chronic Indeterminate Chagas Disease (NCT03587766)Drugs for Neglected Diseases2017-11-13
Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial) (NCT03213665)National Cancer Institute (NCI)2017-11-13
A Study of Cobimetinib Administered as Single Agent and in Combination With Venetoclax, With or Without Atezolizumab, in Participants With Relapsed and Refractory Multiple Myeloma (NCT03312530)Hoffmann-La Roche2017-11-13
Dose Range Study to Evaluate the Efficacy and Safety of AV5080 in Patients With Influenza (NCT05095545)Viriom2017-11-13
Nivolumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery (NCT03342911)Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University2017-11-13
DNS-3379 vs. Placebo in Stroke Rehabilitation (NCT03254160)Dart NeuroScience, LLC2017-11-13
Obinutuzumab Containing Conditioning Regimen for Patients With Poor Risk CLL or Richter's Transformation Requiring Allogeneic Stem Cell Transplantation (NCT03153514)German CLL Study Group2017-11-13
Effects of Dapagliflozin in Non-diabetic Patients With Proteinuria (NCT03190694)Hiddo Lambers Heerspink2017-11-12
Pharmacokinetics and Dynamics of Dexmedetomidine as Adjuvant in TAP Block (NCT03328299)Assiut University2017-11-11
Evaluation of Immediately Placed Dental Implants With Local Application of Injectable PRF in Periodontally Compromised Sites (NCT04029779)Krishnadevaraya College of Dental Sciences & Hospital2017-11-11
Losartan and Inflammation in Cystic Fibrosis (NCT03206788)University of Miami2017-11-11
Study to Evaluate the Safety and Efficacy of JTE-051 in Subjects With Moderate to Severe Plaque Psoriasis (NCT03358290)Akros Pharma Inc.2017-11-10
LCI-GI-APX-NIN-001: Nintedanib in Metastatic Appendiceal Carcinoma (NCT03287947)Wake Forest University Health Sciences2017-11-10
Pembrolizumab as Neoadjuvant Treatment in HCC (NCT03337841)Kindai University2017-11-10
Study of Evinacumab (REGN1500) in Participants With Persistent Hypercholesterolemia (NCT03175367)Regeneron Pharmaceuticals2017-11-10
A Study of Debio 1347 Plus Fulvestrant in Patients With Metastatic Breast Cancer (NCT03344536)Memorial Sloan Kettering Cancer Center2017-11-10
ACTH as A Re-emerging theRapy for Uveitis (The ACTHAR Study) (NCT02931175)Quan Dong Nguyen2017-11-10
BEN-2001 in Parkinson Disease Patients With Excessive Daytime Sleepiness (NCT03194217)BenevolentAI Bio2017-11-10
Study to Evaluate EBA, Safety and Tolerability of Carbapenems in Adults With Pulmonary Tuberculosis (NCT05896930)TASK Applied Science2017-11-09
A Pilot Evaluation of BLI4900 Bowel Preparation in Adult Subjects (NCT03328507)Braintree Laboratories2017-11-09
A Study of LY3154207 in Participants With Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or Dementia With Lewy Bodies (DLB) (NCT03305809)Eli Lilly and Company2017-11-09
Clinical Trial Assessing the Efficacy of Capsaicin Patch (Qutenza®) in Cancer Patients With Neuropathic Pain (NCT03317613)Centre Hospitalier Universitaire de Saint Etienne2017-11-09
Imatinib for Cytomegalovirus Prophylaxis and Treatment After Allogeneic Hematopoietic Stem Cell Transplantation (NCT03343600)National Taiwan University Hospital2017-11-09
Anti-PD-L1 and SAbR for Ovarian Cancer (NCT03312114)University of Texas Southwestern Medical Center2017-11-09
PET-Directed Therapy With Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Classical Hodgkin Lymphoma (NCT03226249)Northwestern University2017-11-09
The Safety and Efficacy of OPC-64005 in the Treatment of Adult Attention-deficit/Hyperactivity Disorder (NCT03324581)Otsuka Pharmaceutical Development & Commercialization, Inc.2017-11-09
TAS-102 (Lonsurf) in Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma Post First Line Chemotherapy (UF-STO-PANC-003) (NCT02921737)University of Florida2017-11-09
Clinical Study to Investigate the Efficacy and Safety of Orally Administered SA001 in Patients With Dry Eye Syndrome. (NCT03723798)Samjin Pharmaceutical Co., Ltd.2017-11-08
Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial) (NCT03220035)National Cancer Institute (NCI)2017-11-08
Efficacy, Tolerability, and Pharmacokinetics of Multiple Doses of Oral TAK-831 in Adults With Friedreich Ataxia (NCT03214588)Neurocrine Biosciences2017-11-08
Pretreatment Staging of High-Risk Prostate Cancer With 18F-Fluciclovine PET/MRI (NCT03264456)University of Alabama at Birmingham2017-11-08
Phase 2 Study of Imprime PGG & Pembrolizumab in Subjects With Adv SCCHN Who Failed Pembro Monotherapy or Experiencing SD (NCT03246685)HiberCell, Inc.2017-11-08
REVERSE-AKI Randomized Controlled Pilot Trial (NCT03251131)Helsinki University Central Hospital2017-11-08
QDISS Stud: QD Isentress as Switch Strategy in Virologically Suppressed HIV-1 Infected-Patient (NCT03195452)Nantes University Hospital2017-11-08
Clinical Study With Ibrutinib and Venetoclax for Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (NCT04754035)Paolo Ghia2017-11-08
Biomarkers Investigation of Neoadjuvant Chemotherapy for Breast Cancer (NCT03242551)Shenzhen People's Hospital2017-11-08
Atezolizumab, Guadecitabine, and CDX-1401 Vaccine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT03206047)National Cancer Institute (NCI)2017-11-08
Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) (NCT03138655)Takeda2017-11-08
Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors. (NCT03345485)Mundipharma Research Limited2017-11-08
IRX-2 Regimen in Treating Women With Cervical Squamous Intraepithelial Neoplasia 3 or Squamous Vulvar Intraepithelial Neoplasia 3 (NCT03267680)University of Southern California2017-11-08
Neoadjuvant Dabrafenib, Trametinib and/or Pembrolizumab in BRAF Mutant Resectable Stage III Melanoma (NCT02858921)Melanoma Institute Australia2017-11-08
Phase II Trial of Pembrolizumab in Recurrent or Residual High Grade Meningioma (NCT03279692)Massachusetts General Hospital2017-11-07
A Trial of Mepolizumab Adjunctive Therapy for the Prevention of Asthma Exacerbations in Urban Children (NCT03292588)National Institute of Allergy and Infectious Diseases (NIAID)2017-11-07
Laser Interstitial Thermal Therapy and Lomustine in Treating Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma (NCT03022578)M.D. Anderson Cancer Center2017-11-07
A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) (NCT03254485)Akebia Therapeutics2017-11-07
Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast Cancer (NCT03301350)University of Wisconsin, Madison2017-11-07
Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain Tumors (NCT03194906)St. Jude Children's Research Hospital2017-11-07
Platelet Aggregation in Patients With Coronary Artery Disease and Kidney Dysfunction Taking Clopidogrel or Ticagrelor (NCT03039205)University of Sao Paulo2017-11-07
Effect of Bifidobacterium Animalis Subsp. Lactis HN019 on Oral Lichen Planus (NCT03386643)University of Sao Paulo2017-11-06
Azacitidine and Pembrolizumab in Treating Patients With Myelodysplastic Syndrome (NCT03094637)M.D. Anderson Cancer Center2017-11-06
Safety and Efficacy Study in Patients With Retinitis Pigmentosa Due to Mutations in PDE6B Gene (NCT03328130)eyeDNA Therapeutics2017-11-06
Naloxegol and Opioid-induced Constipation (NCT03316859)TriHealth Inc.2017-11-06
Pegylated Liposomal Doxorubicin Versus Pirarubicin Plus Ifosfamide, Dacarbazine in Locally Advanced, Unresectable or Metastatic Soft-tissue Sarcoma (NCT03342300)Peking University People's Hospital2017-11-06
A Phase 1/2a Study to Determine the Dose Response Pharmacokinetics of TSX-011 (Testosterone Undecanoate) in Hypogonadal Males (NCT03335254)TesoRx Pharma, LLC2017-11-06
Study of Niraparib and TSR-042 in Recurrent Endometrial Cancer (NCT03016338)University Health Network, Toronto2017-11-06
Efficacy and Safety Study of SUNPG1622 (NCT02980705)Sun Pharmaceutical Industries Limited2017-11-06
QUILT-3.060: NANT Pancreatic Cancer Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy (NCT03329248)ImmunityBio, Inc.2017-11-06
Gene Transfer Clinical Trial to Deliver rAAVrh74.MCK.GALGT2 for Duchenne Muscular Dystrophy (NCT03333590)Kevin Flanigan2017-11-06
Study to Assess the Efficacy and Safety of CJM112 in Patients With Inadequately Controlled Severe Asthma (NCT03299686)Novartis Pharmaceuticals2017-11-06
A Dose Ranging Study of OPT-302 With Ranibizumab in Neovascular (Wet) AMD (NCT03345082)Opthea Limited2017-11-06
A Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma (NCT03250273)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2017-11-06
Laboratory-Treated (Central Memory/Naive) CD8+ T Cells in Treating Patients With Newly Diagnosed or Relapsed Acute Myeloid Leukemia (NCT02770820)Fred Hutchinson Cancer Center2017-11-06
Consultation, Advice, and Tailored Support (CATS) for Cancer Survivors (NCT03316170)Jessica Burris2017-11-06
The Efficacy of Salvage BGD With autoSCT Consolidation in Advanced Classical HL Patients Not Responding to ABVD (NCT03615664)Polish Lymphoma Research Group2017-11-06
Hyperpolarized Xenon-129 MRI: a New Multi-dimensional Biomarker to Determine Pulmonary Physiologic Responses to COPD Therapeutics (NCT03002389)University of Virginia2017-11-05
A Study to Assess Efficacy of HL036 in Subjects With Dry Eyes (NCT03334539)HanAll BioPharma Co., Ltd.2017-11-05
Continuous vs Intermittent Dabrafenib Plus Trametinib in BRAFV600 Mutant Stage 3 Unresectable or Metastatic Melanoma (NCT03352947)Cambridge University Hospitals NHS Foundation Trust2017-11-03
Phase 2B/3 Double-blinded Placebo-controlled (NCT03107377)Evofem Inc.2017-11-03
Flu Vaccine Response in Patients on Biologic Therapies (NCT03277703)Stony Brook University2017-11-03
A Double-blind Randomized Placebo-controlled Study of Safety and Immunogenicity of GamEvac-Lyo (NCT03333538)Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation2017-11-03
Safety, Tolerability, and Pharmacodynamics of IONIS-DGAT2Rx in Adult Patients With Type 2 Diabetes (NCT03334214)Ionis Pharmaceuticals, Inc.2017-11-03
A Study to Assess the Efficacy of a Heterologous Prime/Boost Vaccine Regimen of Ad26.Mos4.HIV and Aluminum Phosphate-Adjuvanted Clade C gp140 in Preventing Human Immunodeficiency Virus (HIV) -1 Infection in Women in Sub-Saharan Africa (NCT03060629)Janssen Vaccines & Prevention B.V.2017-11-03
Ruxolitinib + Allogeneic Stem Cell Transplantation in AML (NCT03286530)Massachusetts General Hospital2017-11-03
Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma (NCT03220009)National Cancer Institute (NCI)2017-11-03
Pembrolizumab and Magnetic Resonance Imaging With Ferumoxytol in Treating Patients With Non-small Cell Lung Cancer and Brain Metastases (NCT03325166)OHSU Knight Cancer Institute2017-11-03
Pembrolizumab Activity in Patients With Homologous Recombination Competent and Deficient Tumors (NCT03274661)Baptist Health South Florida2017-11-03
AssessinG Efficacy of Carboplatin and ATezOlizumab in Metastatic Lobular Breast Cancer (NCT03147040)The Netherlands Cancer Institute2017-11-02
Testing Afatinib in Combination With Pembrolizumab in Patients With Squamous Cell Carcinoma of the Lung (NCT03157089)Boehringer Ingelheim2017-11-02
Apalutamide in Treating Patients With Prostate Cancer Who Are in Active Surveillance (NCT02721979)University of Washington2017-11-02
Pedometer Activity Monitoring After ASCT (NCT03238599)Insel Gruppe AG, University Hospital Bern2017-11-02
Does Caffeine Enhance Bowel Recovery After Colorectal Surgery? (NCT03097900)Hadassah Medical Organization2017-11-02
Efectiveness of Donor IL-15-stimulated NK Cells Post Transplant Infusion in in Acute Leukemia (NCT03669172)Martín, José Luis Díez, M.D.2017-11-02
Antiretroviral Treatment Guided by Proviral Genotype: Pilot Trial of Proof of Concept. (NCT03539224)Instituto de Investigación Hospital Universitario La Paz2017-11-02
DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing Gastric Cancer [DESTINY-Gastric01] (NCT03329690)Daiichi Sankyo Co., Ltd.2017-11-02
A Study of Experimental Medication BMS-986251, Taken by Mouth, in Healthy Participants and Patients With Average to Very Serious Psoriasis (NCT03329885)Bristol-Myers Squibb2017-11-02
Handwriting Interventions for People With Parkinson's (NCT03369587)Oxford Brookes University2017-11-02
Ramucirumab Plus Irinotecan for Previously Treated Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma (NCT03141034)Washington University School of Medicine2017-11-01
A Study of Apatinib Plus Radiotherapy and S-1 for Treatment of Refractory or Metastatic Esophageal Squamous Cell Carcinoma (NCT03320629)Hebei Medical University Fourth Hospital2017-11-01
Topiramate and Prolonged Exposure (NCT03176953)VA Office of Research and Development2017-11-01
PET/CT Imaging of uPAR-expression in Patients With Neuroendocrine Tumors Using 68Ga-NOTA-AE105 (NCT03278275)Rigshospitalet, Denmark2017-11-01
The Effect of an Oral Supplement,TK3 (Tryptophan and Thiamine) on the Quality of Life and Chemotherapy Tolerance in Cancer Patients With Advanced Disease. (NCT03341286)Faculdade de Medicina do ABC2017-11-01
Lactoferrin Versus Total Dose Infusion (TDI) For Treating Iron Deficiency Anemia in Pregnancy: Role of Nursing (NCT03279536)Woman's Health University Hospital, Egypt2017-11-01
Tocilizumab vs Azathioprine in Neuromyelitis Optica Spectrum Disorders (NCT03350633)Tianjin Medical University General Hospital2017-11-01
← Previous Next →

Track Phase 2 automatically

Every clearance here is in the API, with alerts when new ones post.